• All Cancers
• UK Cancer Mortality
• England and Wales Cancer Survival
• Childhood cancer
• 26 types of cancer
• Geographic variations
• Causes of cancer
  • Lifestyle and cancer
  • Infectious Agents
    • Viruses and cancer
    • HTLV1 retrovirus
    • HPVs
    • Epstein-Barr virus
    • KSHV
    • Hepatitis viruses
    • Helicobacter pylori
  • Genes and cancer
• About CancerStats Reports
• FAQs

Helicobacter pylori

This page contains information on Helicobacter pylori infection including Gastric carcinoma and Gastric "MALT" lymphoma.

Helicobacter pylori (H.pylori) is not a virus at all but a bacterium, in fact one of very few bacteria that are able to survive and grow in the stomach. About half the world's population are infected with H-pylori, the highest rates of infection being in poorer countries where and it is mainly contracted in childhood1.

Chronic infection causes an inflammation of the stomach that in many people goes unnoticed but in others leads to gastric or duodenal ulcers. A long-term consequence of chronic infection is that H. pylori-infected people have a 4- to 6-fold increased risk of subsequently developing gastric adenocarcinoma, the most common form of stomach cancer worldwide2, 3, 4.

H. pylori causes about 60% of stomach cancers in developed countries and the fall in rates of gastric cancer in many countries has been linked to decreasing prevalence of H. pylori infection. Infected people are also at risk of developing a rare B cell tumour, so called MALT lymphoma5. Both types of cancer provide examples of how a bacterium, an agent that (unlike a virus) does not grow inside target cells, can nevertheless predispose such cells to becoming malignant by indirect means.

Download this map (27KB)

Back to top ^

Gastric carcinoma

How H. pylori predisposes gastric epithelial cells to become cancerous is not fully understood6. However one clue is that only certain strains of H. pylori, with a set of additional genes involved in protein secretion, are particularly linked to gastric carcinoma. Such strains are able to inject one of these additional protein products, CagA, into epithelial cells, and the cellular changes induced by this protein appear important to the onocogenic process. Equally important is the fact that H. pylori infection induces inflammation of the stomach, leading to the release of a variety of chemical messengers ('cytokines') from the incoming inflammatory cells. People who carry 'high producer' versions of particular cytokine genes are found to be at special risk of cancer development, so clearly over-production of these natural chemicals affects the local environment and increases the chances of cancerous change. Cancer development is a slow process and by the time gastric carcinoma appears, the H. pylori infection itself has often subsided. By then the initiating role played by H. pylori in the cancer process is already complete.

Gastric "MALT" lymphoma

The link between H. pylori infection and MALT lymphoma illustrates how subtle indirect mechanisms of tumour causation can be7, 8. Part of the chronic inflammatory response to H. pylori described above involves T cells that specifically recognise the bacterial infection and try to remove it by secreting particular cytokines. In response to these signals, B cells are attracted into the area and start to grow and divide. The chronic stimulation of these B cells by H. pylori-specific T cells increases the chances of them acquiring accidental chromosomal translocations. Specific chromosomal changes are seen in MALT lymphomas and their analysis has led to the identification of hitherto undiscovered oncogenes. Although oncogene activation is clearly important in the development of MALT lymphomas, tumour growth often remains dependent on the cytokines produced by T cells reacting to the H. pylori infection. So the bacterium is still there when the lymphoma arises, and its removal by antibiotic treatment leads in the majority of cases to a complete cessation of lymphoma growth.

Back to top ^

References for Helicobacter pylori and cancer

1. Parkin, D.M., The global health burden of infection-associated cancers in the year 2002. Int J Cancer, 2006. p.3030-44
2. IARC, Schistosomes, liver flukes and Helicobacter pylori. IARC Monograph 61, in, Editor^Editors. 1994: Lyon.
3. Marshall, B., Helicobacter pylori: 20 years on. Clin Med, 2002. 2(2): p.147-52.
4. Pinto Santini, D. and N.R. Salama, The biology of Helicobacter pylori infection, a major risk factor for gastric adenocarcinoma. Biomarkers Prev, 2005. 14(8): p. 1853-1858.
5. Parsonnet, J. and P.G. Isaacson, Bacterial Infection and MALT lymphoma. N Engl J Med, 2004. 350: p. 213-215.
6. Stoicov, C., R. Saffari, and X.e.a. Cai, Molecular biology of gastric cacner: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth. Gene, 2004. 341: p. 1-17.
7. Isaacson, P.G. and M.Q. Du, MALT lymphoma: from morphology to molecules. Nature Rev Cancer, 2004. 4: p. 644-653.
8. Isaacson, P.G. and M.Q. Du, Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol, 2005. 205: p. 255-274.

Back to top ^